Osteoporotic bone formation in mice lacking tob2; involvement of Tob2 in RANK ligand expression and osteoclasts differentiation
Open Access
- 20 March 2008
- journal article
- Published by Wiley in FEBS Letters
- Vol. 582 (9) , 1313-1318
- https://doi.org/10.1016/j.febslet.2008.03.012
Abstract
Mice lacking tob2, a member of the antiproliferative family genes, had decreased bone mass, and the number of osteoclasts differentiated from bone marrow cells was increased. Overexpression of Tob2 in stromal cells repressed vitamin D3‐induced osteoclasts formation. Furthermore, expression of RANKL mRNA in stromal cells was increased in the absence of Tob2 and decreased in the presence of Tob2. Tob2 interacted with vitamin D3 receptor (VDR), which suggests its involvement in vitamin D3 receptor‐mediated regulation of transcription. Because VDR regulates RANKL expression, our data suggest that Tob2 negatively regulates formation of osteoclasts by suppressing RANKL expression through its interaction with VDR.Keywords
This publication has 20 references indexed in Scilit:
- Tob genes in development and homeostasisDevelopmental Dynamics, 2007
- Oligo-astheno-teratozoospermia in mice lacking Cnot7, a regulator of retinoid X receptor betaNature Genetics, 2004
- Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosisProceedings of the National Academy of Sciences, 2004
- Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosisJournal of Bone and Mineral Metabolism, 2002
- Vitamin D3 Augments Osteoclastogenesis via Vitamin D-Responsive Element of Mouse RANKL Gene PromoterBiochemical and Biophysical Research Communications, 2002
- Relationships of the Antiproliferative Proteins BTG1 and BTG2 with CAF1, the Human Homolog of a Component of the Yeast CCR4 Transcriptional ComplexPublished by Elsevier ,2001
- Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinasesOncogene, 1999
- The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature OsteoclastsThe Journal of cell biology, 1999
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Targeted mutation of the DNA methyltransferase gene results in embryonic lethalityPublished by Elsevier ,1992